2020 Fiscal Year Final Research Report
The Development of system for drug delivery to the bones using low molecular weight heparin to promote bone regeneration
| Project/Area Number |
18K09023
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Review Section |
Basic Section 56020:Orthopedics-related
|
|---|
| Research Institution | Gifu University |
|---|
Principal Investigator |
Nozawa Satoshi 岐阜大学, 医学部附属病院, 講師 (20771679)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
秋山 治彦 岐阜大学, 大学院医学系研究科, 教授 (60402830)
|
|---|
| Project Period (FY) |
2018-04-01 – 2021-03-31
|
| Keywords | 低分子ヘパリン |
|---|
| Outline of Final Research Achievements |
We successfully made special low molecular weight heparin with some conjugation. The products were purified by molecular selective column.
A day after we applied the conjugates with FITC in P5 mice, it was delivered to the bone tissue specifically.
|
| Free Research Field |
脊椎脊髄外科
|
| Academic Significance and Societal Importance of the Research Achievements |
我々の開発した化合物とBMPやFGFと併用することにより、従来骨癒合の遷延がみられた部位（脊椎固定術における椎間移植骨など）の骨癒合を促進させることが期待される。これにより、患者の外固定装着期間を短縮させられる可能性があり、社会的に有益な研究である。
|
